Bilateral serous retinal detachment and uveitis associated with pembrolizumab treatment in metastatic melanoma
Conclusion:
Pembrolizumab therapy may cause the development of panuveitis, papillitis, and serous retinal detachment, symptoms which are able to be controlled with lengthy steroid therapy.
Source: Retinal Cases and Brief Reports - Category: Opthalmology Tags: Case Report Source Type: research
More News: Angiography | Melanoma | Opthalmology | Prednisolone | Prednisone | Skin | Skin Cancer | Steroid Therapy | Vitamin A